Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
alternate, benchmark, competitive, exploration, feedback, found, investor, issuer, nonclinical, secondary
Removed:
country, easily, end, evolution, evolved, fourth, headcount, herd, higher, immunity, incidence, increasing, ineffective, introduced, Johnson, manufactured, Moderna, mortality, Pfizer, presentation, proven, reached, reducing, resumed, spread, stoppage, temporary, unvaccinated, vaccination, variant, widely
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view